SPP1 is a prognostic related biomarker and correlated with tumor-infiltrating immune cells in ovarian cancer

被引:35
作者
Gao, Wen [1 ]
Liu, Dongli [2 ]
Sun, Haiyan [1 ]
Shao, Zhuyan [1 ]
Shi, Peipei [3 ]
Li, Tingting [3 ]
Yin, Sheng [3 ]
Zhu, Tao [1 ]
机构
[1] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Inst Basic Med & Canc IBMC, Chinese Acad Sci,Canc Hosp, Hangzhou 310022, Zhejiang, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Radiat Oncol, Sch Med, Shanghai 200080, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Obstet & Gynecol, 180 Fenglin Rd, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
SPP1; Ovarian cancer; Prognostic; Tumor immune infiltration; Database mining; BONE SIALOPROTEIN; WEB SERVER; OSTEOPONTIN; EXPRESSION; STATISTICS; SURVIVAL; ANTIBODY; SAFETY;
D O I
10.1186/s12885-022-10485-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Secreted phosphoprotein 1 (SPP1) plays a vital role in tumor progression of multiple cancer types However, it still awaits further exploration whether SPP1 is a bystander or an actual player in the modulation of immune infiltration in ovarian cancer. Methods: In this study, the expression level of SPP1 was identified by Oncomine, GEPIA and TIMER databases, and the result of SPP1 immumohistochemical staining was acquired by The HPA database. The impact of SPP1 expression level on the clinical outcome of ovarian cancer patients were evaluated via Kaplan-Meier Plotter and PrognoScan dataset. Immune infiltration analyses were conducted using TIMER and TISIDB dataset. In addition, Functional enrichment analyses were performed with Metascape and GeneMANIA database. To verify these findings from the public database, the results were validated in a cohort of ovarian cancer patients. Results: SPP1 was found to be overexpressed in ovarian tumor tissues and high SPP1 expression was correlated with shorter survivals. Notably, SPP1 expression was positively correlated with infiltrating levels of CD4 + T cells, CD8 + T cells, macrophages, neutrophils, and dendritic cells. Furthermore, SPP1 expression level showed strong correlation with diverse immune cells in ovarian cancer. Of note, functional enrichment analysis suggested that SPP1 was strongly correlated with immune response. Conclusions: These findings imply that SPP1 is correlated with prognosis and immune cell infiltrating, offering a new potential immunotherapeutic target in ovarian cancer.
引用
收藏
页数:12
相关论文
共 44 条
[1]   Tumor-Infiltrating Lymphocyte Grade Is an Independent Predictor of Sentinel Lymph Node Status and Survival in Patients With Cutaneous Melanoma [J].
Azimi, Farhad ;
Scolyer, Richard A. ;
Rumcheva, Pavlina ;
Moncrieff, Marc ;
Murali, Rajmohan ;
McCarthy, Stanley W. ;
Saw, Robyn P. ;
Thompson, John F. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) :2678-2683
[2]   Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer [J].
Brahmer, Julie R. ;
Tykodi, Scott S. ;
Chow, Laura Q. M. ;
Hwu, Wen-Jen ;
Topalian, Suzanne L. ;
Hwu, Patrick ;
Drake, Charles G. ;
Camacho, Luis H. ;
Kauh, John ;
Odunsi, Kunle ;
Pitot, Henry C. ;
Hamid, Omid ;
Bhatia, Shailender ;
Martins, Renato ;
Eaton, Keith ;
Chen, Shuming ;
Salay, Theresa M. ;
Alaparthy, Suresh ;
Grosso, Joseph F. ;
Korman, Alan J. ;
Parker, Susan M. ;
Agrawal, Shruti ;
Goldberg, Stacie M. ;
Pardoll, Drew M. ;
Gupta, Ashok ;
Wigginton, Jon M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2455-2465
[3]   Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a pro-regenerative phenotype [J].
Capote, Joana ;
Kramerova, Irina ;
Martinez, Leonel ;
Vetrone, Sylvia ;
Barton, Elisabeth R. ;
Sweeney, H. Lee ;
Miceli, M. Carrie ;
Spencer, Melissa J. .
JOURNAL OF CELL BIOLOGY, 2016, 213 (02) :275-288
[4]   Cancer statistics: updated cancer burden in China Preface [J].
Chen, Wanqing .
CHINESE JOURNAL OF CANCER RESEARCH, 2015, 27 (01) :1-1
[5]  
Fedarko Neal S, 2004, FASEB J, V18, P734
[6]  
Fedarko NS, 2001, CLIN CANCER RES, V7, P4060
[7]   Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer [J].
Gao, Qinglei ;
Yang, Zongyuan ;
Xu, Sen ;
Li, Xiaoting ;
Yang, Xin ;
Jin, Ping ;
Liu, Yi ;
Zhou, Xiaoshui ;
Zhang, Taoran ;
Gong, Cheng ;
Wei, Xiao ;
Liu, Dan ;
Sun, Chaoyang ;
Chen, Gang ;
Hu, Junbo ;
Meng, Li ;
Zhou, Jianfeng ;
Sawada, Kenjiro ;
Fruscio, Robert ;
Grunt, Thomas W. ;
Wischhusen, Jorg ;
Vargas-Hernandez, Victor Manuel ;
Pothuri, Bhavana ;
Coleman, Robert L. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2019, 216 (03) :688-703
[8]   Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer [J].
Hamanishi, Junzo ;
Mandai, Masaki ;
Ikeda, Takafumi ;
Minami, Manabu ;
Kawaguchi, Atsushi ;
Murayama, Toshinori ;
Kanai, Masashi ;
Mori, Yukiko ;
Matsumoto, Shigemi ;
Chikuma, Shunsuke ;
Matsumura, Noriomi ;
Abiko, Kaoru ;
Baba, Tsukasa ;
Yamaguchi, Ken ;
Ueda, Akihiko ;
Hosoe, Yuko ;
Morita, Satoshi ;
Yokode, Masayuki ;
Shimizu, Akira ;
Honjo, Tasuku ;
Konishi, Ikuo .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (34) :4015-+
[9]   Best predictors of survival outcome after tertiary cytoreduction in patients with recurrent platinum-sensitive epithelial ovarian cancer [J].
Hizli, Deniz ;
Boran, Nurettin ;
Yilmaz, Saynur ;
Turan, Taner ;
Altinbas, Sadiman Kiykac ;
Celik, Bulent ;
Kose, M. Faruk .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2012, 163 (01) :71-75
[10]   Overexpression of osteopontin is associated with more aggressive phenotypes in human non-small cell lung cancer [J].
Hu, Z ;
Lin, DM ;
Yuan, JS ;
Xiao, T ;
Zhang, HS ;
Sun, WY ;
Han, NJ ;
Ma, Y ;
Di, XB ;
Gao, MX ;
Ma, JF ;
Zhang, JH ;
Cheng, SJ ;
Gao, YN .
CLINICAL CANCER RESEARCH, 2005, 11 (13) :4646-4652